Bronchopulmonary effects of a reduction in oxygen content of blood perfusing the pulmonary artery.
D000818:Animals; D001243:Assisted Circulation; D001775:Blood Circulation; D001794:Blood Pressure; D001980:Bronchi / Q000503:physiopathology; D003250:Constriction; D004285:Dogs; D004548:Elasticity; D006439:Hemodynamics; D000860:Hypoxia / Q000503:physiopathology*; D008168:Lung / Q000503:physiopathology; D008170:Lung Compliance; D009638:Norepinephrine / Q000494:pharmacology; D011650:Pulmonary Alveoli; D011651:Pulmonary Artery / Q000187:drug effects / Q000503:physiopathology*; D011652:Pulmonary Circulation; D012119:Respiration; D012137:Respiratory System / Q000503:physiopathology*; D014655:Vascular Resistance
D009638:Norepinephrine